Humana, Baylor Scott & White impasse leaves some seniors out in the cold
Barry Fincher, a 73-year-old Waxahachie resident, is currently enrolled in a Humana Medicare Advantage plan. He said he plans ...
Humana Inc. stock underperforms Wednesday when compared to competitors
Shares of Humana Inc. HUM slid 1.11% to $279.49 Wednesday, on what proved to be an all-around positive trading session for ...
What's Going On With Humana Stock?
Humana shares are trading lower by 3.7% during Thursday's session. Shares are lower following UnitedHealth Group's earnings ...
Humana's Growth Vs. Rising Costs: Why It's A Hold For Cautious Investors
Learn why Humana is focusing on Medicare Advantage and healthcare services despite current challenges, with potential for ...
Here's Why it is Prudent for Investors to Hold Humana Stock for Now
HUM remains well-poised for growth, attributable to improved premiums, contract wins, acquisitions, collaborations and ...
Biogen Beats Humana's RICO Suit Over MS Drug Scheme on Appeal
Humana Inc. fell short of pleading standards in its racketeering lawsuit against Biogen Inc. over its allegedly fraudulent ...
A Glimpse Into The Expert Outlook On Humana Through 7 Analysts
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $285.43, with a ...
Zacks.com on MSN2d
Will Humana (HUM) Beat Estimates Again in Its Next Earnings Report?
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jim Cramer on Humana Inc. (HUM): ‘Medicare Provisions Were Much Better Than Expected On Friday. Should Really Help Humana All Day’
We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...
Humana price target raised to $288 from $270 at Piper Sandler
Piper Sandler raised the firm’s price target on Humana (HUM) to $288 from $270 and keeps a Neutral rating on the shares. The firm says its 2026 ...
Quad-City Times16d
Humana, MercyOne fail to reach agreement by Jan. 1 deadline
The hospital system said this impacts patients who are covered by a Humana Medicare Advantage plan for the 2025 benefit year.
Bernstein Remains a Buy on Humana (HUM)
In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Humana (HUM – Research Report), with a price target of ...